MDWD (MediWound Ltd.) Stock Financials & Earnings | Market Cap Arena

MDWD (MediWound Ltd.) Stock Financials & Earnings | Market Cap Arena

MDWDMediWound Ltd.

Mkt Cap$189M

Healthcare·Biotechnology·🇮🇱 Israel·NASDAQ

Revenue (TTM)$21M

Net Income (TTM)-$21M

EPS (TTM)-$1.90

Free Cash Flow (TTM)-$18M

Gross Margin18.5%

Op. Margin-112.5%

Net Margin-98.4%

FCF Margin-86.1%

P/S Ratio (TTM)9.0x

P/E Ratio (TTM)—

YoY Rev Growth+6.1%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$12M	$8M	$2M
Q1 23	$4M	$826K	-$4M
Q2 23	$5M	$1M	-$4M
Q3 23	$5M	$896K	-$3M
Q4 23	$5M	$719K	-$4M
Q1 24	$5M	$607K	-$4M
Q2 24	$5M	$447K	-$4M
Q3 24	$4M	$677K	-$5M
Q4 24	$6M	$903K	-$6M
Q1 25	$4M	$738K	-$5M
Q2 25	$6M	$1M	-$6M
Q3 25	$5M	$896K	-$7M

Valuation

Quarter	P/S	P/E
Q4 22	7.1x	—
Q1 23	7.3x	—
Q2 23	7.3x	—
Q3 23	7.6x	—
Q4 23	10.1x	—
Q1 24	9.5x	—
Q2 24	9.4x	—
Q3 24	9.6x	—
Q4 24	9.4x	—
Q1 25	9.8x	—
Q2 25	9.5x	—
Q3 25	9.0x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	$2M	$2M
Q1 23	$652K	-$853K
Q2 23	-$5M	-$6M
Q3 23	-$3M	-$5M
Q4 23	-$2M	-$4M
Q1 24	-$4M	-$5M
Q2 24	-$4M	-$7M
Q3 24	-$4M	-$5M
Q4 24	-$2M	-$2M
Q1 25	-$4M	-$5M
Q2 25	-$6M	-$7M
Q3 25	-$3M	-$4M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$174K
Q1 23	$2M
Q2 23	$1M
Q3 23	$2M
Q4 23	$2M
Q1 24	$1M
Q2 24	$3M
Q3 24	$1M
Q4 24	$806K
Q1 25	$959K
Q2 25	$1M
Q3 25	$1M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	+111.7%	+1.2%
Q1 23	-13.8%	+6.1%
Q2 23	+2.2%	+9.3%
Q3 23	-17.7%	-13.8%
Q4 23	-54.1%	+1.1%
Q1 24	+30.7%	+6.6%
Q2 24	+6.1%	+8.7%
Q3 24	-8.8%	+17.6%
Q4 24	+9.4%	+29.3%
Q1 25	-20.3%	+5.5%
Q2 25	+12.7%	+19.7%
Q3 25	+24.7%	+26.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$642K	5.5%
Q1 23	$619K	16.3%
Q2 23	$712K	14.9%
Q3 23	$311K	6.5%
Q4 23	$298K	5.6%
Q1 24	$512K	10.3%
Q2 24	$758K	15.0%
Q3 24	$1M	24.0%
Q4 24	$822K	14.1%
Q1 25	$844K	21.3%
Q2 25	$862K	15.1%
Q3 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q4 22	$3M	$3M
Q1 23	$2M	$3M
Q2 23	$2M	$3M
Q3 23	$2M	$3M
Q4 23	$2M	$3M
Q1 24	$1M	$3M
Q2 24	$2M	$3M
Q3 24	$3M	$3M
Q4 24	$3M	$4M
Q1 25	$3M	$3M
Q2 25	$3M	$4M
Q3 25	$3M	$4M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$34M	$0	$34M
Q1 23	$51M	$6M	$57M
Q2 23	$51M	$0	$51M
Q3 23	$9M	$36M	$46M
Q4 23	$12M	$30M	$42M
Q1 24	$36M	$0	$36M
Q2 24	$4M	$25M	$29M
Q3 24	$6M	$39M	$46M
Q4 24	$9M	$0	$9M
Q1 25	$38M	$0	$38M
Q2 25	$1M	$31M	$32M
Q3 25	$59M	$0	$59M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	6M	+32.4%
Q1 23	8M	+32.4%
Q2 23	9M	+9.8%
Q3 23	9M	+0.1%
Q4 23	9M	+0.0%
Q1 24	9M	+0.2%
Q2 24	9M	+0.5%
Q3 24	11M	+13.3%
Q4 24	11M	+2.7%
Q1 25	11M	+0.1%
Q2 25	11M	+0.3%
Q3 25	11M	+1.7%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 13	—	—
FY 14	$4K	63
FY 15	$9K	67
FY 16	$29K	54
FY 17	$42K	60
FY 18	$56K	61
FY 19	$513K	62
FY 20	$335K	65
FY 21	$355K	67
FY 22	$363K	73
FY 23	$212K	88
FY 24	$108K	188